{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:02:17Z","timestamp":1747454537242,"version":"3.40.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,15]]},"DOI":"10.7759\/cureus.84203","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:06:40Z","timestamp":1747375600000},"source":"Crossref","is-referenced-by-count":0,"title":["Holistic Management of Multiple Myeloma: A Case Report on Siddha Therapy as an Adjunct to the Bortezomib-Lenalidomide-Dexamethasone (BLD) Regimen"],"prefix":"10.7759","author":[{"given":"Bharathi","family":"Baskar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akila","family":"B","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0141","article-title":"Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment","volume":"25","author":"Ludwig H","year":"2020","unstructured":"Ludwig H, Novis Durie S, Meckl A, Hinke A, Durie B. Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment. Oncologist. 2020, 25:e1406-13. 10.1634\/theoncologist.2020-0141","journal-title":"Oncologist"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031649","article-title":"Multiple myeloma: challenges encountered and future options for better treatment","volume":"23","author":"Das S","year":"2022","unstructured":"Das S, Juliana N, Yazit NA, Azmani S, Abu IF. Multiple myeloma: challenges encountered and future options for better treatment. Int J Mol Sci. 2022, 23:10.3390\/ijms23031649","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611750","article-title":"Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma","volume":"376","author":"Attal M","year":"2017","unstructured":"Attal M, Lauwers-Cances V, Hulin C, et al.. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma. N Engl J Med. 2017, 376:1311-20. 10.1056\/NEJMoa1611750","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235933","article-title":"Integrative approaches to the treatment of cancer","volume":"14","author":"O'Brien K","year":"2022","unstructured":"O'Brien K, Ried K, Binjemain T, Sali A. Integrative approaches to the treatment of cancer. Cancers (Basel). 2022, 14:10.3390\/cancers14235933","journal-title":"Cancers (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113096","article-title":"Pancreatic cancer (PDAC): introduction of evidence-based complementary measures into integrative clinical management","volume":"12","author":"Jentzsch V","year":"2020","unstructured":"Jentzsch V, Davis JA, Djamgoz MB. Pancreatic cancer (PDAC): introduction of evidence-based complementary measures into integrative clinical management. Cancers (Basel). 2020, 12:10.3390\/cancers12113096","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/136527","article-title":"Chloroform extract of Rasagenthi Mezhugu, a Siddha formulation, as an evidence-based complementary and alternative medicine for HPV-positive cervical cancers","volume":"2012","author":"Riyasdeen A","year":"2012","unstructured":"Riyasdeen A, Periasamy VS, Paul P, Alshatwi AA, Akbarsha MA. Chloroform extract of Rasagenthi Mezhugu, a Siddha formulation, as an evidence-based complementary and alternative medicine for HPV-positive cervical cancers. Evid Based Complement Alternat Med. 2012, 2012:136527. 10.1155\/2012\/136527","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-004-0770-9","article-title":"Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer","volume":"54","author":"Ranga RS","year":"2004","unstructured":"Ranga RS, Girija R, Nur-e-Alam M, et al.. Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer. Cancer Chemother Pharmacol. 2004, 54:7-15. 10.1007\/s00280-004-0770-9","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5530\/ijper.51.4s.108","article-title":"Investigation of in vitro antioxidant and anti-inflammatory activities of selected siddha polyherbal formulations","volume":"51","author":"Rajalakshmi P","year":"2017","unstructured":"Rajalakshmi P, Vadivel V, Brindha P. Investigation of in vitro antioxidant and anti-inflammatory activities of selected siddha polyherbal formulations. Indian J Pharm Educ Res. 2017, 51:747-53. 10.5530\/ijper.51.4s.108","journal-title":"Indian J Pharm Educ Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7324\/JAPS.2023.126389","article-title":"Pre-clinical studies of Siddha formulations advocated for anaemia: a systematic review and meta-analysis","volume":"13","author":"Arumugam RK","year":"2023","unstructured":"Arumugam RK, Gunalan G, Firdouse KHH, Arivazhagan A. Pre-clinical studies of Siddha formulations advocated for anaemia: a systematic review and meta-analysis. J Appl Pharm Sci. 2023, 13:185-203. 10.7324\/JAPS.2023.126389","journal-title":"J Appl Pharm Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.01.016","article-title":"Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model","volume":"66","author":"Yang CJ","year":"2009","unstructured":"Yang CJ, Wang CS, Hung JY, et al.. Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model. Lung Cancer. 2009, 66:162-8. 10.1016\/j.lungcan.2009.01.016","journal-title":"Lung Cancer"},{"key":"ref11","article-title":"Pharmacological evaluation of anti-anaemic activity of Siddha herbal formulation - Madhulai Manappagu","volume":"19","author":"Meenakshi Sundaram M","year":"2020","unstructured":"Meenakshi Sundaram M, Vanitha A, Logamanian M, et al.. Pharmacological evaluation of anti-anaemic activity of Siddha herbal formulation - Madhulai Manappagu. IOSR J Dent Med Sci. 2020, 19:30-5.","journal-title":"IOSR J Dent Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1023\/a:1014405730585","article-title":"Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer","volume":"71","author":"Kim ND","year":"2002","unstructured":"Kim ND, Mehta R, Yu W, et al.. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat. 2002, 71:203-17. 10.1023\/a:1014405730585","journal-title":"Breast Cancer Res Treat"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1995-7645(11)60201-0","article-title":"Antipyretic, anti-inflammatory and analgesic properties of nilavembu kudineer choornam: a classical preparation used in the treatment of chikungunya fever","volume":"4","author":"Anbarasu K","year":"2011","unstructured":"Anbarasu K, Manisenthil KK, Ramachandran S. Antipyretic, anti-inflammatory and analgesic properties of nilavembu kudineer choornam: a classical preparation used in the treatment of chikungunya fever. Asian Pac J Trop Med. 2011, 4:819-23. 10.1016\/S1995-7645(11)60201-0","journal-title":"Asian Pac J Trop Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S2221-1691(13)60059-3","article-title":"The development of Terminalia chebula Retz. (Combretaceae) in clinical research","volume":"3","author":"Bag A","year":"2013","unstructured":"Bag A, Bhattacharyya SK, Chattopadhyay RR. The development of Terminalia chebula Retz. (Combretaceae) in clinical research. Asian Pac J Trop Biomed. 2013, 3:244-52. 10.1016\/S2221-1691(13)60059-3","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000520312","article-title":"Multiple myeloma: molecular pathogenesis and disease evolution","volume":"44","author":"Heider M","year":"2021","unstructured":"Heider M, Nickel K, H\u00f6gner M, Bassermann F. Multiple myeloma: molecular pathogenesis and disease evolution. Oncol Res Treat. 2021, 44:672-81. 10.1159\/000520312","journal-title":"Oncol Res Treat"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan AJ","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, et al.. Diagnosis and management of multiple myeloma: a review. JAMA. 2022, 327:464-77. 10.1001\/jama.2022.0003","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_431554","article-title":"Integrative therapies in cancer care: an update on the guidelines","volume":"44","author":"Gowin K","year":"2024","unstructured":"Gowin K, Muminovic M, Zick SM, Lee RT, Lacchetti C, Mehta A. Integrative therapies in cancer care: an update on the guidelines. Am Soc Clin Oncol Educ Book. 2024, 44:e431554. 10.1200\/EDBK_431554","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi110","article-title":"Use of complementary and alternative medicine in cancer patients: a European survey","volume":"16","author":"Molassiotis A","year":"2005","unstructured":"Molassiotis A, Fern\u00e1ndez-Ortega P, Pud D, et al.. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005, 16:655-63. 10.1093\/annonc\/mdi110","journal-title":"Ann Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11050816","article-title":"Functional and nutraceutical significance of Amla (Phyllanthus emblica L.): a review","volume":"11","author":"Gul M","year":"2022","unstructured":"Gul M, Liu ZW, Iahtisham-Ul-Haq, et al.. Functional and nutraceutical significance of Amla (Phyllanthus emblica L.): a review. Antioxidants (Basel). 2022, 11:10.3390\/antiox11050816","journal-title":"Antioxidants (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22010177","article-title":"Pomegranate for prevention and treatment of cancer: an update","volume":"22","author":"Sharma P","year":"2017","unstructured":"Sharma P, McClees SF, Afaq F. Pomegranate for prevention and treatment of cancer: an update. Molecules. 2017, 22:10.3390\/molecules22010177","journal-title":"Molecules"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359676-holistic-management-of-multiple-myeloma-a-case-report-on-siddha-therapy-as-an-adjunct-to-the-bortezomib-lenalidomide-dexamethasone-bld-regimen","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:06:41Z","timestamp":1747375601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359676-holistic-management-of-multiple-myeloma-a-case-report-on-siddha-therapy-as-an-adjunct-to-the-bortezomib-lenalidomide-dexamethasone-bld-regimen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.84203","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,15]]}}}